Dr Isida Byku (Structural Heart and Valve Center, Emory University, Atlanta, GA, US) joins us to discuss how the latest evidence for mitral transcatheter edge-to-edge repair is informing patient selection and refining clinical practice.

Interview Questions:

1. How has the evidence base for mitral TEER evolved, and what are the most consequential recent findings for clinical practice?
2. How does contemporary evidence inform patient selection across degenerative and functional mitral regurgitation?
3. Which anatomical and physiological factors are most important when identifying patients likely to benefit from TEER?
4. What role does the Heart Team play in navigating areas of clinical uncertainty and competing treatment options?
5. How are device iteration and emerging data influencing procedural strategy and expected outcomes?
6. What are your key take-home messages for clinicians applying contemporary mitral TEER evidence to patient selection?

Recorded on-site at New York Valves 2026, New York.
Editors: Jordan Rance

Videographer: TBC
Support: This is an independent interview produced by Transcatheter Academy.